Episode

CTAS Stock: Cintas Popped 7% on Earnings — But It’s ~40x. Buy It?

Podcast
Charged Alpha Stock Encyclopedia
Published
Jul 16, 2026
Duration seconds
611
Processing state
not_requested
Canonical source
https://chargedalpha.podbean.com/e/ctas-stock-cintas-popped-7-on-earnings-%e2%80%94-but-it-s-40x-buy-it/
Audio
https://mcdn.podbean.com/mf/web/s5dxly00rdgjr0ai/audio_v.mp3
JSON
/v1/public/podcasts/charged-alpha-stock-encyclopedia-7819792/episodes/ctas-stock-cintas-popped-7-on-earnings-but-it-s-40x-buy-it
Markdown
/podcast/charged-alpha-stock-encyclopedia-7819792/ctas-stock-cintas-popped-7-on-earnings-but-it-s-40x-buy-it.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/charged-alpha-stock-encyclopedia-7819792/episodes/ctas-stock-cintas-popped-7-on-earnings-but-it-s-40x-buy-it/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792/ctas-stock-cintas-popped-7-on-earnings-but-it-s-40x-buy-it.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Cintas (CTAS) Q4 FY2026 — Cintas (CTAS), the uniform-rental and facility-services compounder, reported fiscal Q4 2026: revenue up ~7% to $2.9B, adjusted EPS $1.29 (beat $1.24), operating margin over 23%. The stock popped ~7%. It's a wide-moat, recurring-revenue machine (route density, ~23% margins, cross-selling first aid/safety and fire protection) — one of the best-performing stocks of the past few decades. But near ~$206 (~9% off its $227 high) it trades at ~40x earnings for ~8-10% growth. The Street is split — a Hold consensus, target ~$231. Cintas is one of the most boring businesses in the market — renting uniforms and supplying mats, first-aid kits and fire extinguishers — and one of the best-performing stocks of the last few decades. It just beat again (fiscal Q4 revenue +7% to $2.9B, adjusted EPS $1.29, ~23% operating margin) and popped ~7%. The moat is route density: once its trucks serve a neighborhood, the next customer is nearly free, driving best-in-class margins and relentless, recurring-revenue compounding via new customers, cross-selling, and price. There's no turnaround to debate — the only question is the price. At ~40x earnings for ~8-10% growth, it's priced for perfection: our owner-earnings work lands fair value near $203, essentially right at the ~$206 price, with no margin of safety. Our call: HOLD, 3/5 — an elite compounder we'd love to own cheaper. Own it if you have it; wait for a market pullback toward the mid-$170s if you don't. Not financial advice. THE CALL: HOLD (3/5, AN ELITE COMPOUNDER, PRICED FOR PERFECTION) — base-case value ~$205 vs ~$206 today. What to watch: a broad market pullback that takes it toward the mid-$170s (a rare cheap entry), or growth reaccelerating above 10% (via cross-selling or M&A) that lets the ~40x multiple…